feed,title,long_url,short_url
Benzinga,Fennec Pharma Stock Plunges On Expected FDA CRL For Pedmark For Chemo-Induced Hearing Issues,https://benzinga.com/general/biotech/21/11/24325880/fennec-pharma-stock-plunges-on-expected-fda-crl-for-pedmark-for-chemo-induced-hearing-issues,https://j.mp/3cX8VhA
